Tesla Stock Climbs 3% Ahead of Q2 2026 Results as Analysts Clash Over Margins, Capex and Robotaxi Credibility
Hims & Hers CEO Andrew Dudum Unfazed by Market Swings, Sets Sights on Revolutionizing Healthcare's Future
Gain Therapeutics Shares Soar: Unpacking the Preclinical Breakthrough in Parkinson's and Gaucher Disease